Loteprednol Etabonate

Loteprednol Etabonate

Definition

The etabonate salt form of loteprednol, an ophthalmic analog of the corticosteroid prednisolone with anti-inflammatory activity. Loteprednol etabonate exerts its effect by interacting with specific intracellular receptors and subsequently binds to DNA to modify gene expression. This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Loteprednol etabonate specifically induces phospholipase A2 inhibitory proteins (collectively called lipocortins), which inhibit the release of arachidonic acid, thereby inhibiting the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes.

Also known as Alrex, Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, chloromethyl Ester,(11beta,17alpha)-, Lotemax, LOTEPREDNOL ETABONATE — per NCIT

Also identified as

Indications

Disease Relation Source
Bacterial conjunctivitis may treat MEDRT · Public domain (U.S. Government work)
Iritis may treat MEDRT · Public domain (U.S. Government work)
Keratitis may treat MEDRT · Public domain (U.S. Government work)
Rosacea may treat MEDRT · Public domain (U.S. Government work)
Viral conjunctivitis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Camera-type eye may treat a disease of this organ DERIVED · CC BY 4.0
Conjunctiva may treat a disease of this organ DERIVED · CC BY 4.0
Cornea may treat a disease of this organ DERIVED · CC BY 4.0
Craniocervical region may treat a disease of this organ DERIVED · CC BY 4.0
Ocular adnexa may treat a disease of this organ DERIVED · CC BY 4.0
Skin of body may treat a disease of this organ DERIVED · CC BY 4.0

6 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.